Navigation Links
Custom 60-mer Oligonucleotide Microarrays from Agilent Technologies

ProductsCustom 60-mer Oligonucleotide Microarrays from Agilent Technologies
Company Agilent Technologies
Item Custom 60-mer Oligonucleotide Microarrays
Price 
Description These extended-length microarrays are custom designed to meet your needs. Two probe density format configurations are available: 8,455 features per array (2 arrays/1" x 3" glass slide) or 22,575 features per array (1 array/slide).

Features

  • 60-mer oligonucleotide probe length - This extended length delivers higher sensitivity compared to traditional shorter length probes. It also allows for the design of microarrays with fewer, more selective probes.
  • Two Microarray Layout Design Formats
    • 8,455 features/array, 2 microarrays/slide
    • 22,575 features/slide, 1 microarray/slide
  • Probes arrayed on 1" x 3" glass slides - Oligonucleotide probes are arrayed on glass slides designed for optimal results in the Agilent Microarray Scanner.
  • Two-Color Labeling Protocols - Agilent protocols allows you to simultaneously run differential gene expression analysis all in a single microarray experiment. This reduces analysis time as well as any potential microarray-to-microarray experimental variability.
  • Agilent's Custom-designed Hybridization Chambers - Agilent's chambers enable the employment of a unique "mixing bubble" for more uniform hybridization reactions.
  • Agilent SurePrint Technology - Fast. Flexible. Reliable. Agilent prints its microarrays in their industrial-scale inkjet-based printing facility equipped with its SurePrint technology. Print what you want, when you want it, in the quantity you want. When you need to adjust your microarray design by adding new gene content, rely on Agilent to deliver "up-to-date" custom microarrays without the need for elaborate mask designs. Inkjet printing is creating a whole new experience in delivering custom microarrays from Agilent.
  • Affordable, Adaptable, and Accessible - These are key attributes of Agilents Custom Microarray Technology Access Program. At Agilent, our industrial-scale inkjet printing process allows for fast-turn, affordable high-quality custom printed microarrays. Say good-bye to slow-turn microarrays with high set-up costs and/or fees.
Info Agilent TechnologiesAgilent Technologies


US and Canada
395 Page Mill Rd.
P.O. Box #10395
Palo Alto, CA 94303
USA

For Agilent contacts in other countries
please click here.

Customer Service: 1-800-227-9770/1-302-993-5304
Web Site: http://www.agilent.com/chem
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
2. Custom Arraying Service from Whatman, Inc
3. Custom 2-OMe RNA Aptamer Microarray from LC Sciences
4. Custom DNA Aptamer Microarray from LC Sciences
5. Custom 2-F RNA Aptamer Microarray from LC Sciences
6. Custom Peptide Microarray - Comprehensive Service from LC Sciences
7. Custom DNA Microarray from LC Sciences
8. Custom Antibody Production Services from Aves Labs, Inc.
9. EvoQuest ™ Custom Laboratory Services from Invitrogen
10. Custom Processing Service from Whatman, Inc
11. Custom Phosphopeptide Microarray from LC Sciences
... The Zero Background/Kan Cloning Kit ... kanamycin resistance for selection in ... utilizes positive selection to eliminate ... all of the reagents you ...
GOAT ANTI SLI...
Protein Phosphorylation...
ANTI L-DOPA...
Biology Products:
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/4/2014)... GARDENS, Fla. , Dec. 3, 2014 /PRNewswire/ ... solutions, today announced that its DigitalPersona ® ... fingerprint readers have been deployed throughout First Bank ... , South Carolina and ... in Southern Pines, North Carolina ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... technical, managerial and financial components of healthcare delivery to ... Disease) patient will be the topic of Stevens Institute ... October 31, 2007, from 3-5 p.m. in Room 122 ... Streets in Hoboken, NJ). , Roundtable participants will discuss ...
... a 46 percent increase in lifespan, raising the tantalizing ... are also taking an anti-aging medication. Results of the ... Lithgow, PhD, are currently published online in the Journal ... to treat mood affective disorders, including bipolar disease for ...
... daily commute may be taking more of a toll than ... of Southern California (USC) and the California Air Resources Board ... exposure to harmful air pollutants occurs while people are traveling ... spends about six percent (1.5 hours) of his or her ...
Cached Biology News:Stevens Health, Technology, and Society roundtable: Oct. 31 2Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 2Time spent in car drives up air pollution exposure 2
(Date:12/19/2014)... LayerBio is an MIT spin-off developing novel ... National Eye Institute (NEI) at the National Institutes of ... grant to develop a drug-eluting intraocular lens (IOL) for ... of vision loss in people over age 40 and ... Ken Mandell, LayerBio’s Founder and CEO, "There is a ...
(Date:12/19/2014)... December 19, 2014 The empty ... the rising ageing population and technological innovations in ... nutraceutical industries are catalysing the growth of the ... http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report , ... well as new entrants/smaller firms to gauge the ...
(Date:12/19/2014)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced the results of its annual general meeting ... transformational year in Relmada,s history and it set the ... Sergio Traversa , chief executive officer of Relmada. ... financial, human resource and clinical development objectives that position ...
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8